subject: CHEMBL.COMPOUND:CHEMBL4594472

object_name: metastatic gastrointestinal carcinoid tumor


subject: CHEMBL.COMPOUND:CHEMBL4594472

object_name: Neoplasm Metastasis

tested_intervention: unsure


subject: CHEMBL.COMPOUND:CHEMBL4594472

object_name: neoplasm


subject: UMLS:C4764036

object_name: Metastatic Digestive System Neuroendocrine Tumor G1


subject: UMLS:C4764036


subject: UMLS:C4764036


subject: UMLS:C4764036


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: insomnia

tested_intervention: yes


subject: UMLS:C4305940

object_name: HIV infection


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:25681

object_name: immunodeficiency disease


subject: UNII:CS4U38E731

subject_name: Nigella sativa oil


subject: UNII:CS4U38E731


subject: UMLS:C4053591

subject_name: Ripertamab

object_name: diffuse large B-cell lymphoma


subject: UMLS:C5401619


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:182913

object_name: amyotrophic lateral sclerosis


subject: CHEBI:8356

subject_name: Pramipexole


subject: CHEBI:8356


subject: UMLS:C4053827

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4053827

object_name: clear cell renal carcinoma


subject: UMLS:C4053827

object_name: renal cell adenocarcinoma


subject: UMLS:C4053827

object_name: renal cell carcinoma


subject: UMLS:C0939354

subject_name: Indomethacin SR

object_name: acute pancreatitis


subject: UMLS:C0939354

object_name: multiple organ dysfunction syndrome


subject: UMLS:C0939354

object_name: mortality


subject: UMLS:C0939354

object_name: complication


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Loss of Chromosome 17p


subject: CHEBI:91397

object_name: chromosome 17p deletion


subject: CHEBI:231614

subject_name: Nivolumab

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:231614

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:43Y934BBZ6

object_name: hepatitis C


subject: UNII:43Y934BBZ6

object_name: hepatitis B


subject: CHEMBL.COMPOUND:CHEMBL4297813


subject: CHEMBL.COMPOUND:CHEMBL4297813


subject: UNII:ZL1R02VT79

subject_name: Ranibizumab

object_name: Eales disease


subject: MESH:C020245

subject_name: canephron N

object_name: urinary tract infection


subject: MESH:C020245

object_name: bacterial urinary tract infection


subject: MESH:C020245

object_name: Urinary Tract Infection, CTCAE


subject: DRUGBANK:DB05189

object_name: Advanced cancer


subject: CHEBI:91397

object_name: cancer


subject: CHEBI:91397

object_name: neoplasm


subject: UMLS:C3886728

object_name: gout


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: thrombocytopenia 1


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: CHEBI:42724

subject_name: levamfetamine

object_name: endogenous depression


subject: CHEBI:42724

object_name: major depressive disorder


subject: CHEBI:35338

subject_name: amphetamines


subject: CHEBI:35338


subject: CHEBI:132233

subject_name: Amphetamine


subject: CHEBI:132233


subject: UMLS:C1971782

subject_name: DEXTROAMPHETAMINE SULFATE, 5 MG ADMINISTERED


subject: UMLS:C1971782


subject: CHEBI:4469

subject_name: dexamfetamine


subject: CHEBI:4469


subject: CHEBI:35677

subject_name: Betahistine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:35677

object_name: obesity


subject: CHEBI:35677

object_name: Obesity, CTCAE


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:9831414

object_name: ductal breast carcinoma in situ


subject: PUBCHEM.COMPOUND:9831414

object_name: lobular breast carcinoma in situ


subject: PUBCHEM.COMPOUND:9831414

object_name: Atypical hyperplasia of breast


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: UNII:D87YGH4Z0Q


subject: UNII:D87YGH4Z0Q


subject: CHEBI:41774

subject_name: Tamoxifen


subject: CHEBI:41774


subject: MESH:C000722901

object_name: common wart


subject: MESH:C000722901

object_name: viral sexually transmitted disease


subject: MESH:C000722901

object_name: human papilloma virus infection


subject: MESH:C000722901

object_name: sexually transmitted disease


subject: MESH:C000722901

object_name: skin disorder caused by infection


subject: MESH:C000722901

object_name: skin infection


subject: MESH:C000722901

object_name: Skin Diseases, Viral


subject: MESH:C000722901

object_name: skin disorder


subject: MESH:C000722901

object_name: Condylomata acuminata in women


subject: MESH:C000722901

object_name: Genital warts


subject: MESH:C000722901

object_name: Condylomata acuminata in men


subject: UMLS:C3272757

subject_name: Live attenuated Influenza virus antigen only vaccine product

object_name: pneumonia


subject: UMLS:C3272757

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:42797

subject_name: Gabapentin

object_name: pain agnosia


subject: CHEBI:42797

object_name: Pain insensitivity


subject: CHEBI:42797

object_name: Inguinal hernia


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: ovarian carcinoma


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:895VG117HN

subject_name: Celgosivir

object_name: hepatitis C


subject: UNII:895VG117HN

object_name: chronic hepatitis C virus infection


subject: CHEBI:92998

subject_name: Guanabenz

object_name: Embolism, Tumor


subject: CHEBI:92998

object_name: Neoplasm Metastasis


subject: CHEBI:92998

object_name: Metastasis


subject: CHEBI:92998

object_name: Metastatic Lesion


subject: CHEBI:92998

object_name: bone cancer


subject: CHEBI:92998

object_name: Osteosarcoma


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: Resectable non-small cell lung cancer


subject: UMLS:C0003234

subject_name: Anthracycline Antibiotics

object_name: adult acute myeloid leukemia


subject: UMLS:C0003234

object_name: childhood acute myeloid leukemia


subject: UMLS:C0003234

object_name: acute myeloid leukemia


subject: CHEBI:48120

subject_name: anthracycline


subject: CHEBI:48120


subject: CHEBI:48120


subject: CHEBI:2948

subject_name: Azathioprine


subject: CHEBI:2948


subject: CHEBI:2948


subject: UMLS:C0733521

subject_name: Ara-C


subject: UMLS:C0733521


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: lupus nephritis


subject: CHEBI:61057

object_name: end stage renal failure


subject: CHEBI:61057

object_name: EXCESS LMW-DNA


subject: CHEBI:61057

object_name: st. Louis encephalitis


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026

object_name: Chronic uremia


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:71957

object_name: adult lymphoma


subject: CHEBI:71957

object_name: lymphoma


subject: CHEBI:71957

object_name: pediatric lymphoma


subject: CHEBI:71957

object_name: cancer


subject: CHEBI:71957

object_name: neoplasm


subject: UNII:60ES45KTMK

subject_name: Pilaralisib


subject: UNII:60ES45KTMK


subject: UNII:60ES45KTMK


subject: UNII:60ES45KTMK


subject: UMLS:C3657458


subject: UMLS:C3657458


subject: UMLS:C3657458


subject: UMLS:C3657458


subject: UNII:LR3UXN0193

subject_name: Methoxy polyethylene glycol-epoetin beta

object_name: anemia


subject: UNII:LR3UXN0193

object_name: Anemia, CTCAE


subject: CHEBI:4445

subject_name: Desflurane

object_name: Post-Operative Pain


subject: CHEBI:6015

subject_name: Isoflurane


subject: CHEBI:9130

subject_name: Sevoflurane


subject: UMLS:C1882421

subject_name: defined green tea catechin extract

object_name: Cirrhosis


subject: UMLS:C1882421

object_name: liver cirrhosis


subject: GTOPDB:12989

subject_name: toripalimab

object_name: cervical cancer


subject: GTOPDB:12989

object_name: cervical carcinoma


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Cutaneous Squamous Cell Carcinoma of the Head and Neck


subject: CHEBI:173763

subject_name: Thermophillin

object_name: cocaine dependence


subject: PUBCHEM.COMPOUND:23597337

subject_name: Physalin L


subject: CHEBI:4659

subject_name: Disulfiram


subject: CHEBI:36704

subject_name: Imiquimod

object_name: kidney failure


subject: CHEBI:36704

object_name: Renal Failure, CTCAE


subject: UMLS:C2348288

subject_name: Dietary Zinc

object_name: hereditary endocrine growth disease


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C4705566

object_name: Upper abdominal pain


subject: UMLS:C5226792


subject: CHEBI:75998

subject_name: Trametinib

object_name: borderline ovarian serous tumor


subject: CHEBI:75998

object_name: Recurrent Ovarian Low Grade Serous Adenocarcinoma


subject: CHEBI:75998

object_name: primary peritoneal serous adenocarcinoma


subject: CHEBI:75998

object_name: peritoneal serous adenocarcinoma


subject: CHEBI:75998

object_name: ovarian serous adenocarcinoma


subject: CHEBI:75998

object_name: Recurrent Primary Peritoneal Serous Adenocarcinoma


subject: CHEBI:75998

object_name: micropapillary serous carcinoma


subject: CHEBI:75998

object_name: papillary serous cystadenocarcinoma


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Secondary Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:1805


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:16118

subject_name: Berberine

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:16118

object_name: obesity


subject: CHEBI:16118

object_name: Obesity, CTCAE


subject: CHEBI:16118

object_name: diabetes mellitus


subject: UMLS:C0937629

subject_name: Gymnema sylvestre preparation


subject: UMLS:C0937629


subject: UMLS:C0937629


subject: UMLS:C0937629


subject: UMLS:C1663585

object_name: hepatitis C


subject: UMLS:C1663585

object_name: chronic hepatitis C virus infection


subject: UMLS:C5203352

subject_name: Carboplatin Liquid Injection

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UMLS:C0499106

subject_name: Injection, carboplatin, 50 mg


subject: UMLS:C0499127

subject_name: Injection, etoposide, 10 mg administered


subject: UMLS:C5203273

subject_name: Etoposide Liquid Injection


subject: UMLS:C4764905

subject_name: Ifosfamide for Injection


subject: UMLS:C5445196

subject_name: Oxaliplatin Liquid Injection


subject: UMLS:C5203254

subject_name: Rituximab Liquid Injection


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Pregnant


subject: UNII:1C6V77QF41

object_name: birth weight


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: UMLS:C5704062

subject_name: Venlafaxine ER

object_name: major depressive disorder


subject: UMLS:C4053606

subject_name: Ivuxolimab

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C4053606

object_name: Carcinoma breast stage IV


subject: UMLS:C4053606

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4053606

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C4053606

object_name: Unresectable Breast Carcinoma


subject: UMLS:C4053606

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C4053606

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C4053606

object_name: Breast cancer stage III


subject: UMLS:C4053606

object_name: Stage III Breast Cancer AJCC v6


subject: UMLS:C4053606

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C4053606

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C4053606

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C4053606

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C4053606

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C4053606

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C4053606

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C4053606

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C4053606

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C4053606

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C4053606

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C4053606

object_name: Breast cancer recurrent


subject: UMLS:C4053606

object_name: triple-negative breast carcinoma


subject: UMLS:C4053606

object_name: invasive breast carcinoma


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:KXG2PJ551I

object_name: Carcinoma breast stage IV


subject: UNII:KXG2PJ551I

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Unresectable Breast Carcinoma


subject: UNII:KXG2PJ551I

object_name: Stage III Breast Cancer AJCC v7


subject: UNII:KXG2PJ551I

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Breast cancer stage III


subject: UNII:KXG2PJ551I

object_name: Stage III Breast Cancer AJCC v6


subject: UNII:KXG2PJ551I

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Stage IIIB Breast Carcinoma


subject: UNII:KXG2PJ551I

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Stage IIIA Breast Carcinoma


subject: UNII:KXG2PJ551I

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:KXG2PJ551I

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:KXG2PJ551I

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:KXG2PJ551I

object_name: Breast cancer recurrent


subject: UNII:KXG2PJ551I

object_name: triple-negative breast carcinoma


subject: UNII:KXG2PJ551I

object_name: invasive breast carcinoma


subject: UMLS:C3896806

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C3896806

object_name: Carcinoma breast stage IV


subject: UMLS:C3896806

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3896806

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3896806

object_name: Unresectable Breast Carcinoma


subject: UMLS:C3896806

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C3896806

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C3896806

object_name: Breast cancer stage III


subject: UMLS:C3896806

object_name: Stage III Breast Cancer AJCC v6


subject: UMLS:C3896806

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C3896806

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C3896806

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3896806

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3896806

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3896806

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3896806

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C3896806

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C3896806

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C3896806

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3896806

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3896806

object_name: Breast cancer recurrent


subject: UMLS:C3896806

object_name: triple-negative breast carcinoma


subject: UMLS:C3896806

object_name: invasive breast carcinoma


subject: CHEBI:145371

subject_name: Binimetinib

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:145371

object_name: Carcinoma breast stage IV


subject: CHEBI:145371

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:145371

object_name: Unresectable Breast Carcinoma


subject: CHEBI:145371

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:145371

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:145371

object_name: Breast cancer stage III


subject: CHEBI:145371

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:145371

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:145371

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:145371

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:145371

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:145371

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:145371

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:145371

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:145371

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:145371

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:145371

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:145371

object_name: Breast cancer recurrent


subject: CHEBI:145371

object_name: invasive breast carcinoma


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: Unresectable Breast Carcinoma


subject: CHEBI:28748

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:28748

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:28748

object_name: Breast cancer stage III


subject: CHEBI:28748

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:28748

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:28748


subject: CHEBI:28748

object_name: triple-negative breast carcinoma


subject: CHEBI:28748


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:156963654

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:156963654

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:156963654

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:156963654

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:156963654

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:156963654

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:156963654

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:156963654

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:156963654

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:156963654

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:156963654

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:156963654

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:156963654

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:156963654


subject: PUBCHEM.COMPOUND:156963654

object_name: invasive breast carcinoma


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO


subject: UNII:DA64T2C2IO

object_name: Unresectable Breast Carcinoma


subject: UNII:DA64T2C2IO

object_name: Stage III Breast Cancer AJCC v7


subject: UNII:DA64T2C2IO

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UNII:DA64T2C2IO

object_name: Breast cancer stage III


subject: UNII:DA64T2C2IO

object_name: Stage III Breast Cancer AJCC v6


subject: UNII:DA64T2C2IO

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UNII:DA64T2C2IO

object_name: Stage IIIB Breast Carcinoma


subject: UNII:DA64T2C2IO

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:DA64T2C2IO

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:DA64T2C2IO

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UNII:DA64T2C2IO

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UNII:DA64T2C2IO

object_name: Stage IIIA Breast Carcinoma


subject: UNII:DA64T2C2IO

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UNII:DA64T2C2IO

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:DA64T2C2IO

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UNII:DA64T2C2IO

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UNII:DA64T2C2IO

object_name: Breast cancer recurrent


subject: UNII:DA64T2C2IO

object_name: invasive breast carcinoma


subject: UMLS:C3640943

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C3640943

object_name: Carcinoma breast stage IV


subject: UMLS:C3640943

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3640943

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3640943

object_name: Unresectable Breast Carcinoma


subject: UMLS:C3640943

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C3640943

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C3640943

object_name: Breast cancer stage III


subject: UMLS:C3640943

object_name: Stage III Breast Cancer AJCC v6


subject: UMLS:C3640943

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C3640943

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C3640943

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3640943

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3640943

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3640943

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3640943

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C3640943

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C3640943

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C3640943

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3640943

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3640943

object_name: Breast cancer recurrent


subject: UMLS:C3640943

object_name: invasive breast carcinoma


subject: GTOPDB:9244

subject_name: utomilumab

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: GTOPDB:9244

object_name: Carcinoma breast stage IV


subject: GTOPDB:9244

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: GTOPDB:9244

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: GTOPDB:9244

object_name: Unresectable Breast Carcinoma


subject: GTOPDB:9244

object_name: Stage III Breast Cancer AJCC v7


subject: GTOPDB:9244

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: GTOPDB:9244

object_name: Breast cancer stage III


subject: GTOPDB:9244

object_name: Stage III Breast Cancer AJCC v6


subject: GTOPDB:9244

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: GTOPDB:9244

object_name: Stage IIIB Breast Carcinoma


subject: GTOPDB:9244

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: GTOPDB:9244

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: GTOPDB:9244

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: GTOPDB:9244

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: GTOPDB:9244

object_name: Stage IIIA Breast Carcinoma


subject: GTOPDB:9244

object_name: Stage IIIC Breast Cancer AJCC v6


subject: GTOPDB:9244

object_name: Stage IIIC Breast Cancer AJCC v7


subject: GTOPDB:9244

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: GTOPDB:9244

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: GTOPDB:9244

object_name: Breast cancer recurrent


subject: GTOPDB:9244

object_name: triple-negative breast carcinoma


subject: GTOPDB:9244

object_name: invasive breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3707324

subject_name: UTOMILUMAB

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Carcinoma breast stage IV


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Unresectable Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Stage III Breast Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Breast cancer stage III


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Stage III Breast Cancer AJCC v6


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Stage IIIB Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Stage IIIA Breast Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: Breast cancer recurrent


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: triple-negative breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL3707324

object_name: invasive breast carcinoma


subject: UMLS:C3529795

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C3529795

object_name: Carcinoma breast stage IV


subject: UMLS:C3529795

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3529795

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: UMLS:C3529795

object_name: Unresectable Breast Carcinoma


subject: UMLS:C3529795

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C3529795

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: UMLS:C3529795

object_name: Breast cancer stage III


subject: UMLS:C3529795

object_name: Stage III Breast Cancer AJCC v6


subject: UMLS:C3529795

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: UMLS:C3529795

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C3529795

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3529795

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UMLS:C3529795

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3529795

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: UMLS:C3529795

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C3529795

object_name: Stage IIIC Breast Cancer AJCC v6


subject: UMLS:C3529795

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C3529795

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3529795

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: UMLS:C3529795

object_name: Breast cancer recurrent


subject: UMLS:C3529795

object_name: triple-negative breast carcinoma


subject: UMLS:C3529795

object_name: invasive breast carcinoma


subject: CHEBI:142290

subject_name: Anagrelide

object_name: essential thrombocythemia


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717

object_name: Gastric Mixed Adenocarcinoma


subject: CHEBI:52717

object_name: diffuse gastric adenocarcinoma


subject: CHEBI:52717

object_name: gastric intestinal type adenocarcinoma


subject: CHEBI:52717

object_name: recurrent gastric cancer


subject: CHEBI:52717

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:52717

object_name: Stage IIIC Gastric Cancer AJCC v7


subject: CHEBI:52717

object_name: Stage IIIB Gastric Carcinoma


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: UNII:Y6BX7BL23K

subject_name: Pemigatinib

object_name: mantle cell lymphoma


subject: UNII:Y6BX7BL23K

object_name: marginal zone lymphoma


subject: UNII:Y6BX7BL23K

object_name: MALT lymphoma


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: gastric adenocarcinoma


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: CHEBI:135005

subject_name: Milnacipran

object_name: Common Migraine


subject: CHEBI:135005

object_name: Transformed migraine


subject: CHEBI:135005

object_name: migraine with aura


subject: PUBCHEM.COMPOUND:16129688

subject_name: Cubicin

object_name: diabetic foot


subject: CHEBI:600103

subject_name: daptomycin


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: UNII:WP6PY72ZH3

subject_name: Motolimod

object_name: head and neck squamous cell carcinoma


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: transitional cell carcinoma


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: Parkinson disease


subject: UNII:75G4TW236W

subject_name: Meglumine antimoniate

object_name: cutaneous leishmaniasis


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: lung cancer


subject: CHEBI:175901

object_name: lung carcinoma


subject: UniProtKB:P03230

subject_name: LMP1_EBVB9 Latent membrane protein 1 (sprot)

object_name: leiomyosarcoma


subject: UniProtKB:P03230

object_name: Childhood Leiomyosarcoma


subject: UniProtKB:P03230

object_name: Adult Leiomyosarcoma


subject: UniProtKB:P03230

object_name: Hodgkin Disease


subject: UniProtKB:P03230

object_name: nasopharyngeal type undifferentiated carcinoma


subject: UniProtKB:P03230

object_name: non-Hodgkin lymphoma


subject: CHEBI:77260

subject_name: Omeprazole

object_name: achlorhydria


subject: CHEBI:77260

object_name: Hypochlorhydria


subject: CHEBI:38290

subject_name: L-ascorbate


subject: CHEBI:38290


subject: CHEBI:176783

subject_name: vitamin C


subject: CHEBI:176783


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C3714687


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: UMLS:C2349136


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: CHEBI:22652


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C4522080


subject: UNII:ZU3D90W5GZ

subject_name: lactisole

object_name: Finding of blood glucose level


subject: CHEBI:173971

subject_name: LACTISOLE


subject: CHEBI:5001

subject_name: Fenofibrate

object_name: hypertriglyceridemia


subject: CHEBI:5001

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:7496

subject_name: Nelfinavir


subject: CHEBI:7496

object_name: lung neoplasm


subject: CHEBI:7496


subject: CHEBI:137359

object_name: Blood Pressure Finding


subject: CHEBI:137359

object_name: Systemic arterial pressure


subject: CHEBI:37084

subject_name: beta-Hydroxyisovaleric acid


subject: CHEBI:37084


subject: CHEMBL.COMPOUND:CHEMBL4525124

subject_name: HMB


subject: CHEMBL.COMPOUND:CHEMBL4525124


subject: CHEBI:26708

subject_name: sodium atom


subject: CHEBI:26708


subject: CHEBI:29101

subject_name: Sodium cation


subject: CHEBI:29101


subject: UMLS:C3541959

subject_name: Sodium supplements


subject: UMLS:C3541959


subject: UMLS:C3714642

subject_name: Sodium Drug Class


subject: UMLS:C3714642


subject: UNII:71M78END5S

subject_name: OMEGA-3 FATTY ACIDS

object_name: acute lymphoblastic leukemia


subject: CHEBI:25681

subject_name: Omega-3 fatty acids


subject: CHEBI:231347

subject_name: Triapine

object_name: prostate carcinoma


subject: CHEBI:231347

object_name: prostate cancer


subject: CHEBI:68554

subject_name: Deferiprone

object_name: Chronic iron overload


subject: MESH:C000721066

object_name: Hepatic impairment


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:100241


subject: PUBCHEM.COMPOUND:3222

object_name: Fabry disease


subject: PUBCHEM.COMPOUND:3222

object_name: proteinuria


subject: PUBCHEM.COMPOUND:3222

object_name: Proteinuria of undiagnosed cause


subject: PUBCHEM.COMPOUND:3222

object_name: Proteinuria, CTCAE 3.0


subject: PUBCHEM.COMPOUND:3222

object_name: Proteinuria, CTCAE 5.0


subject: CHEBI:4784

subject_name: Enalapril


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:4784


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:149504


subject: CHEBI:6541

subject_name: Losartan


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: CHEBI:6541


subject: UNII:TL60C27RLH

subject_name: Metreleptin

object_name: congenital generalized lipodystrophy


subject: UNII:TL60C27RLH

object_name: generalized lipodystrophy


subject: PUBCHEM.COMPOUND:165437864

object_name: anxiety


subject: PUBCHEM.COMPOUND:165437864

object_name: anxiety disorder


subject: PUBCHEM.COMPOUND:165437864

object_name: Anxiety symptoms


subject: PUBCHEM.COMPOUND:165437864

object_name: Anxiety, CTCAE 3.0


subject: PUBCHEM.COMPOUND:165437864

object_name: Anxiety, CTCAE 5.0


subject: UNII:372X2P22UY


subject: UNII:372X2P22UY


subject: UNII:372X2P22UY


subject: UNII:372X2P22UY


subject: UNII:372X2P22UY


subject: UNII:A7YT618XBV

subject_name: AS03 adjuvant


subject: UMLS:C1522002

subject_name: RNA Recognition Motif


subject: UMLS:C5667085

subject_name: Bifunctional TGF-beta Antagonist/IL-15 Protein Complex HCW9218

object_name: Childhood Solid Neoplasm


subject: UMLS:C5667085

object_name: Adult Solid Neoplasm


subject: UMLS:C5667085

object_name: Solid Neoplasm


subject: UNII:8M7YSN2KII

subject_name: nortramadol

object_name: lung cancer


subject: UNII:8M7YSN2KII

object_name: lung neoplasm


subject: UNII:8M7YSN2KII

object_name: lung carcinoma


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: UniProtKB:P15379-4


subject: UniProtKB:P15379-4


subject: PUBCHEM.COMPOUND:21014972

subject_name: Telavancin

object_name: gram-positive bacterial infections


subject: CHEBI:8382

subject_name: Prednisone

object_name: Postmenopausal


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:4953

subject_name: Exemestane


subject: PUBCHEM.COMPOUND:21879648

subject_name: Abiraterone


subject: CHEBI:82699

subject_name: Oritavancin


subject: PUBCHEM.COMPOUND:60139

subject_name: (D-Ala1)-Peptide T

object_name: HIV infection


subject: PUBCHEM.COMPOUND:60139

object_name: cognitive disorder


subject: UNII:05DYM3ZS1X

subject_name: Peptide T


subject: UNII:05DYM3ZS1X


subject: UMLS:C0030953

subject_name: peptide-T


subject: UMLS:C0030953


subject: CHEBI:75275

subject_name: Tetradecyl hydrogen sulfate (ester)

object_name: Epithelial cyst


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: pyogenic liver abscess


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:79042

subject_name: Tasimelteon

object_name: Dyssomnias


subject: CHEBI:79042

object_name: Sleep abnormality


subject: CHEBI:79042

object_name: pervasive developmental disorder


subject: CHEBI:79042

object_name: autism


subject: CHEBI:79042

object_name: autism spectrum disorder


subject: CHEBI:79042

object_name: sleep disorder


subject: CHEBI:79042

object_name: nervous system disorder


subject: UMLS:C5908029

subject_name: Anti-HHLA2 Monoclonal Antibody NPX887

object_name: Embolism, Tumor


subject: UNII:A10SJL62JY

subject_name: Ocrelizumab

object_name: Recurrent disease


subject: UNII:A10SJL62JY

object_name: Global Relapse in Viscera


subject: UNII:A10SJL62JY

object_name: Global Relapse in Lymph Nodes


subject: UNII:A10SJL62JY

object_name: Relapse Following Intervention for Kawasaki Disease


subject: UNII:A10SJL62JY

object_name: Global Relapse


subject: UNII:A10SJL62JY

object_name: Global Relapse in Skin


subject: UNII:A10SJL62JY

object_name: Global Relapse in Blood


subject: UNII:A10SJL62JY

object_name: primary progressive multiple sclerosis


subject: UMLS:C5853984

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:139399801

subject_name: Vanzacaftor


subject: CHEBI:135919

subject_name: Nesiritide

object_name: congenital heart disease


subject: CHEBI:95067

subject_name: Iniparib

object_name: Malignant neoplasm of female breast


subject: UMLS:C4706052

object_name: primary biliary cholangitis


subject: MESH:D056692

subject_name: Prebiotics

object_name: Gastrointestinal symptom


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: Solid Neoplasm


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: CHEBI:8988


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: biliary tract cancer


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Rasmussen subacute encephalitis


subject: UMLS:C0295415

subject_name: rituximab


subject: UNII:C8ADC441ME

subject_name: Ivabradine

object_name: Arrhythmia


subject: CHEBI:177298

object_name: glioblastoma


subject: CHEBI:177298

object_name: Childhood Glioblastoma


subject: CHEBI:177298

object_name: adult glioblastoma


subject: CHEBI:177298

object_name: brain cancer


subject: CHEBI:177298

object_name: brain neoplasm


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:176844


subject: CHEBI:32682

subject_name: L-argininium

object_name: MELAS syndrome


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:16467

subject_name: Arginine


subject: UMLS:C2703138

subject_name: ficlatuzumab

object_name: Metastatic malignant neoplasm to liver


subject: UMLS:C2703138

object_name: Malignant Solid Neoplasm


subject: CHEBI:135515

subject_name: Bendamustine

object_name: Plasma cell myeloma refractory


subject: CHEBI:63791

subject_name: Lenalidomide


subject: UNII:JN9F31ZW6Z

subject_name: lanthanum dioxycarbonate

object_name: Chronic kidney disease requiring chronic dialysis


subject: UMLS:C5960109

subject_name: Oxylanthanum Carbonate


subject: CHEBI:8427

subject_name: Probucol

object_name: IgA Nephropathy


subject: CHEBI:8427

object_name: glomerulonephritis


subject: UNII:4I67US2V8Q

object_name: Stress


subject: UNII:4I67US2V8Q

object_name: anxiety


subject: UNII:4I67US2V8Q

object_name: anxiety disorder


subject: UNII:4I67US2V8Q

object_name: Anxiety symptoms


subject: UNII:4I67US2V8Q

object_name: Anxiety, CTCAE 3.0


subject: UNII:4I67US2V8Q

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: diabetic ketoacidosis


subject: DRUGBANK:DB18502

object_name: GM1 gangliosidosis


subject: DRUGBANK:DB18502

object_name: Niemann-Pick disease type C


subject: DRUGBANK:DB18502

object_name: Tay-Sachs disease


subject: DRUGBANK:DB18502

object_name: GM2 gangliosidosis


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: MGMT-Methylated Glioblastoma


subject: CHEBI:68646

object_name: IDH-wildtype glioblastoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: nasopharyngeal carcinoma


subject: GTOPDB:7988

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: CHEBI:52717

subject_name: Bortezomib

object_name: autoimmune thrombocytopenia


subject: CHEBI:52717

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:52717

object_name: autoimmune thrombocytopenic purpura


subject: UMLS:C5706524

subject_name: FGFR4 Inhibitor ABSK-011

object_name: liver carcinoma


subject: UMLS:C4727210

subject_name: Cadonilimab

object_name: cervical cancer


subject: UMLS:C4727210

object_name: cervical carcinoma


subject: CHEBI:50853

subject_name: quantum dot

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:50853

object_name: obesity


subject: CHEBI:50853

object_name: Obesity, CTCAE


subject: CHEBI:93775

subject_name: Amethopterin

object_name: breast neoplasm


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: PUBCHEM.COMPOUND:11556075

subject_name: Contrave

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:11556075

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:11556075

object_name: breast cancer


subject: PUBCHEM.COMPOUND:11556075

object_name: Overweight or obesity


subject: RXCUI:1551466

subject_name: bupropion / naltrexone Extended Release Oral Tablet


subject: RXCUI:1551466


subject: RXCUI:1551466


subject: RXCUI:1551466


subject: PR:000005931

object_name: ovarian cancer


subject: PR:000005931

object_name: ovarian neoplasm


subject: PR:000005931

object_name: ovarian carcinoma


subject: PR:000005931

object_name: Stomach cancer


subject: PR:000005931

object_name: gastric cancer


subject: PR:000005931

object_name: brain neoplasm


subject: UMLS:C0064332

subject_name: keyhole-limpet hemocyanin


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332

object_name: prostate carcinoma


subject: UMLS:C0064332

object_name: prostate cancer


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: UMLS:C0064332


subject: CHEBI:37941

subject_name: Clopidogrel

object_name: Non-ST Elevated Myocardial Infarction


subject: CHEBI:37941

object_name: angina unstable


subject: UNII:TCN4MG2VXS

subject_name: Dapivirine

object_name: AIDS


subject: UNII:D652ZWF066

subject_name: sodium zirconium cyclosilicate

object_name: heart failure


subject: UNII:D652ZWF066

object_name: Heart Failure, CTCAE


subject: UNII:D652ZWF066

object_name: chronic kidney disease


subject: UNII:E569WG6E60

subject_name: Arzoxifene

object_name: postmenopausal osteoporosis


subject: UNII:E569WG6E60

object_name: osteoporosis


subject: GTOPDB:13768

subject_name: cagrilintide

object_name: Overweight or obesity


subject: CHEMBL.COMPOUND:CHEMBL4802169

subject_name: CAGRILINTIDE


subject: UMLS:C2002939

object_name: non-Hodgkin lymphoma


subject: UMLS:C2002939


subject: UMLS:C2002939


subject: UMLS:C2002939

object_name: melanoma


subject: UNII:Z7HVY03PHP

subject_name: Mirikizumab

object_name: ulcerative colitis


subject: UNII:Z7HVY03PHP

object_name: inflammatory bowel disease 1


subject: KEGG.COMPOUND:C00471

subject_name: Plasmin

object_name: Acute Ischemic Stroke


subject: KEGG.COMPOUND:C00471

object_name: Ischemic stroke


subject: UMLS:C0016016

subject_name: plasmin


subject: UMLS:C0016016


subject: PUBCHEM.COMPOUND:135565596

subject_name: Copanlisib

object_name: lymphoma, non-Hodgkin, familial


subject: PUBCHEM.COMPOUND:135565596

object_name: Adult Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:135565596

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:173077


subject: CHEBI:173077


subject: CHEBI:173077


subject: PUBCHEM.COMPOUND:135566117

subject_name: Aliqopa


subject: PUBCHEM.COMPOUND:135566117


subject: PUBCHEM.COMPOUND:135566117


subject: PUBCHEM.COMPOUND:135566117


subject: UMLS:C0796445

subject_name: Cisplatin Liposomal

object_name: Metastatic osteosarcoma


subject: PUBCHEM.COMPOUND:4442

subject_name: Ramosetron

object_name: post operative nausea and vomiting


subject: PUBCHEM.COMPOUND:4442

object_name: Solid Neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone


subject: PUBCHEM.COMPOUND:6433115

subject_name: reparixin

object_name: Fatigue, CTCAE 5.0


subject: PUBCHEM.COMPOUND:6433115

object_name: Fatigue


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: glaucoma


subject: UNII:2S9ZZM9Q9V

object_name: Glaucoma, CTCAE


subject: CHEBI:38940

subject_name: Sunitinib

object_name: Clear-cell metastatic renal cell carcinoma


subject: CHEBI:38940

object_name: Neoplasms by Histologic Type


subject: CHEBI:38940

object_name: Neoplasm of the genitourinary tract


subject: CHEBI:38940

object_name: benign urinary system neoplasm


subject: CHEBI:38940

object_name: urinary system neoplasm


subject: CHEBI:38940

object_name: urinary system disorder


subject: CHEBI:38940

object_name: kidney disorder


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: Diabetic peripheral neuropathy


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:84040


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: UMLS:C0038838

subject_name: superoxide dismutase


subject: PUBCHEM.COMPOUND:6328211

subject_name: Alhydrogel

object_name: malaria


subject: UMLS:C0733770


subject: UMLS:C1134664


subject: UNII:03J11K103C

subject_name: ALGELDRATE


subject: UNII:U21CVV13SV

object_name: adrenal gland neoplasm


subject: UNII:U21CVV13SV

object_name: adrenal carcinoma


subject: UNII:U21CVV13SV

object_name: adrenal cortex carcinoma


subject: CHEBI:228488

subject_name: Stiripentol

object_name: primary hyperoxaluria type 1


subject: CHEBI:228488

object_name: primary hyperoxaluria type 2


subject: CHEBI:228488

object_name: primary hyperoxaluria type 3


subject: CHEBI:231679

subject_name: ipilimumab

object_name: neoplastic meningitis


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: CHEBI:70839

subject_name: Dasatinib

object_name: pancreatic neoplasm


subject: CHEBI:70839

object_name: exocrine pancreatic carcinoma


subject: CHEBI:70839

object_name: malignant pancreatic neoplasm


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Adult Rhabdomyosarcoma


subject: UNII:52CMI0WC3Y

object_name: rhabdomyosarcoma


subject: UNII:52CMI0WC3Y

object_name: Childhood Rhabdomyosarcoma


subject: UNII:52CMI0WC3Y

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: CHEBI:8988

object_name: Childhood Solid Neoplasm


subject: CHEBI:8988

object_name: Adult Solid Neoplasm


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:80630


subject: CHEBI:80630


subject: CHEBI:80630


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658

object_name: Solid Neoplasm


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEMBL.COMPOUND:CHEMBL4650420

subject_name: RECIFERCEPT

object_name: achondroplasia


subject: UMLS:C5421201

subject_name: Recifercept


subject: CHEBI:8093

subject_name: Phenylephrine

object_name: no feeling or sensation of skin


subject: CHEBI:8093

object_name: Sensory Loss


subject: CHEBI:8093

object_name: Disorder of shoulder


subject: CHEBI:5134

subject_name: Fluticasone

object_name: cystic fibrosis


subject: CHEBI:15365

subject_name: Aspirin

object_name: pregnancy related


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: acute lymphoblastic leukemia


subject: UNII:5TAA004E22

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:5TAA004E22

object_name: Recurrent Chronic Lymphoid Leukemia


subject: UNII:5TAA004E22

object_name: Hodgkin Disease


subject: UNII:5TAA004E22

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: UNII:5TAA004E22

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: UNII:5TAA004E22

object_name: Recurrent Non-Hodgkin Lymphoma


subject: UNII:5TAA004E22

object_name: Recurrent Hodgkin Lymphoma


subject: UNII:5TAA004E22

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:5TAA004E22

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:5TAA004E22

object_name: non-Hodgkin lymphoma


subject: UNII:5TAA004E22

object_name: Plasma cell myeloma recurrent


subject: UNII:5TAA004E22

object_name: Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive


subject: UNII:5TAA004E22

object_name: lymphoid leukemia


subject: UNII:5TAA004E22

object_name: acute myeloid leukemia


subject: UNII:5TAA004E22

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: MESH:C000730795

object_name: intestinal cancer


subject: MESH:C000730795

object_name: intestinal polyp


subject: MESH:C000730795

object_name: Stomach cancer


subject: MESH:C000730795

object_name: gastric cancer


subject: MESH:C000730795

object_name: gastric ulcer


subject: MESH:C000730795

object_name: Gastric Ulcer, CTCAE


subject: UMLS:C5814407


subject: UMLS:C5783657

subject_name: Acetylcysteine zidrimer


subject: UNII:21P2M98388

subject_name: Henagliflozin

object_name: diabetic kidney disease


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: pulmonary blastoma


subject: CHEBI:4026

object_name: pleuropulmonary blastoma


subject: CHEBI:4026

object_name: DICER1 syndrome


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:125400

subject_name: actinomycin D


subject: CHEBI:125400


subject: CHEBI:125400


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:27666


subject: CHEBI:50223

subject_name: Dexrazoxane


subject: CHEBI:50223


subject: CHEBI:50223


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:64816


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:63632

subject_name: Topotecan


subject: CHEBI:63632


subject: CHEBI:63632


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:4026

object_name: Adult Gliosarcoma


subject: CHEBI:4026

object_name: gliosarcoma


subject: CHEBI:4026

object_name: Childhood Gliosarcoma


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: UMLS:C3827065


subject: UMLS:C3827065


subject: UMLS:C3827065


subject: UMLS:C3827065

object_name: glioblastoma


subject: UMLS:C3827065

object_name: Childhood Glioblastoma


subject: UMLS:C3827065

object_name: adult glioblastoma


subject: GTOPDB:4942

subject_name: GM-CSF


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: GTOPDB:4942


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: UMLS:C0376563


subject: MESH:C000718835

object_name: lymphoma, non-Hodgkin, familial


subject: MESH:C000718835

object_name: non-Hodgkin lymphoma


subject: MESH:C000718835

object_name: Adult Non-Hodgkin Lymphoma


subject: MESH:C000718835

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:229722

subject_name: camonsertib

object_name: Unresectable Head and Neck Squamous Cell Carcinoma


subject: CHEBI:229722

object_name: Squamous cell carcinoma of head and neck recurrent


subject: CHEBI:229722

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: CHEBI:229722

object_name: Unresectable Oral Cavity Squamous Cell Carcinoma


subject: CHEBI:229722

object_name: Laryngeal squamous cell carcinoma recurrent


subject: CHEBI:229722

object_name: Unresectable Laryngeal Squamous Cell Carcinoma


subject: CHEBI:229722

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: CHEBI:229722

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: CHEBI:229722

object_name: Unresectable Oropharyngeal Squamous Cell Carcinoma


subject: CHEBI:229722

object_name: Unresectable Hypopharyngeal Squamous Cell Carcinoma


subject: CHEBI:229722

object_name: Recurrent Paranasal Sinus Squamous Cell Carcinoma


subject: CHEBI:229722

object_name: Unresectable Paranasal Sinus Squamous Cell Carcinoma


subject: CHEBI:229722

object_name: Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: CHEBI:229722

object_name: Stage IVA Laryngeal Cancer AJCC v8


subject: CHEBI:229722

object_name: Stage IVB Laryngeal Cancer AJCC v8


subject: CHEBI:229722

object_name: Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: CHEBI:229722

object_name: Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: CHEBI:229722

object_name: Stage III Laryngeal Cancer AJCC v8


subject: CHEBI:229722

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:229722

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:229722

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: CHEBI:229722

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:229722

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:229722

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: CHEBI:229722

object_name: Stage IVB Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:229722

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:229722

object_name: Stage IVA Lip and Oral Cavity Cancer AJCC v8


subject: CHEBI:229722

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:S1Z7Y5G56T

subject_name: CAMONSERTIB

object_name: Unresectable Head and Neck Squamous Cell Carcinoma


subject: UNII:S1Z7Y5G56T

object_name: Squamous cell carcinoma of head and neck recurrent


subject: UNII:S1Z7Y5G56T

object_name: Squamous cell carcinoma of the oral cavity recurrent


subject: UNII:S1Z7Y5G56T

object_name: Unresectable Oral Cavity Squamous Cell Carcinoma


subject: UNII:S1Z7Y5G56T

object_name: Laryngeal squamous cell carcinoma recurrent


subject: UNII:S1Z7Y5G56T

object_name: Unresectable Laryngeal Squamous Cell Carcinoma


subject: UNII:S1Z7Y5G56T

object_name: Oropharyngeal squamous cell carcinoma recurrent


subject: UNII:S1Z7Y5G56T

object_name: Hypopharyngeal squamous cell carcinoma recurrent


subject: UNII:S1Z7Y5G56T

object_name: Unresectable Oropharyngeal Squamous Cell Carcinoma


subject: UNII:S1Z7Y5G56T

object_name: Unresectable Hypopharyngeal Squamous Cell Carcinoma


subject: UNII:S1Z7Y5G56T

object_name: Recurrent Paranasal Sinus Squamous Cell Carcinoma


subject: UNII:S1Z7Y5G56T

object_name: Unresectable Paranasal Sinus Squamous Cell Carcinoma


subject: UNII:S1Z7Y5G56T

object_name: Stage III Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage IVA Laryngeal Cancer AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage IVB Laryngeal Cancer AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage IVB Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage IVA Nasal Cavity and Paranasal Sinus Cancer AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage III Laryngeal Cancer AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage IVA Hypopharyngeal Carcinoma AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage IVB Hypopharyngeal Carcinoma AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage III Hypopharyngeal Carcinoma AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage IVB Lip and Oral Cavity Cancer AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage III Lip and Oral Cavity Cancer AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Stage IVA Lip and Oral Cavity Cancer AJCC v8


subject: UNII:S1Z7Y5G56T

object_name: Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8


subject: UNII:6ZA31Y954Z

subject_name: Brodalumab

object_name: psoriasis


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: genetic disease


subject: UNII:NQX9KB6PCL

object_name: Turner syndrome


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: CHEBI:50922

subject_name: Eletriptan

object_name: migraine


subject: CHEBI:50922

object_name: migraine with or without aura, susceptibility to, 1


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: Hodgkin Disease


subject: GTOPDB:9592

object_name: Adult Classical Hodgkin Lymphoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: GTOPDB:7786

subject_name: pascolizumab

object_name: asthma


subject: UNII:N1IOA09R6A

subject_name: PASCOLIZUMAB


subject: UMLS:C2982101

subject_name: Pascolizumab


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: motor neuron disorder


subject: UMLS:C5854523

subject_name: PARP1 Inhibitor HS-10502

object_name: pancreatic neoplasm


subject: UMLS:C5854523

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5854523

object_name: malignant pancreatic neoplasm


subject: UMLS:C5854523

object_name: colorectal cancer


subject: UMLS:C5854523

object_name: colorectal carcinoma


subject: UMLS:C5854523

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C5854523

object_name: prostate cancer


subject: UMLS:C5854523

object_name: ovarian cancer


subject: UMLS:C5854523

object_name: ovarian neoplasm


subject: UMLS:C5854523

object_name: ovarian carcinoma


subject: UMLS:C5854523

object_name: Childhood Breast Carcinoma


subject: UMLS:C5854523

object_name: breast carcinoma


subject: UMLS:C5854523

object_name: breast cancer


subject: UNII:9CZX3Z9945

object_name: Ischemic stroke


subject: UMLS:C4310262


subject: UNII:V7FWP1D62O

subject_name: NERVE GROWTH FACTOR

object_name: Alzheimer disease


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: cervical cancer


subject: CHEBI:50847

subject_name: immunological adjuvant

object_name: Vaccine response impaired


subject: CHEBI:50847

object_name: IMMUNE SUPPRESSION


subject: CHEBI:50847

object_name: Decreased Immunologic Activity [PE]


subject: UMLS:C5854409

subject_name: Ruxoprubart


subject: PUBCHEM.COMPOUND:6328211

subject_name: Alhydrogel

object_name: Plasmodium falciparum malaria


subject: UMLS:C0733770


subject: UNII:03J11K103C

subject_name: ALGELDRATE


subject: CHEBI:77562

subject_name: rac-crizotinib

object_name: neoplasm


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:6931

subject_name: Midazolam

object_name: Hernia


subject: CHEBI:34650

subject_name: COLISTIMETHATE

object_name: Haematological infection


subject: CHEBI:37943

subject_name: colistin


subject: PUBCHEM.COMPOUND:71226663

subject_name: Acalabrutinib

object_name: plasma cell myeloma


subject: CHEBI:6801

subject_name: Metformin

object_name: colon carcinoma


subject: CHEBI:6801

object_name: colorectal cancer


subject: CHEBI:6801

object_name: colon cancer


subject: CHEBI:30830

subject_name: sodium oxybate

object_name: cerebral amyloid angiopathy


subject: CHEBI:30830

object_name: ACys amyloidosis


subject: CHEMBL.COMPOUND:CHEMBL1743024

subject_name: GANITUMAB

object_name: metastatic colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: rectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: rectal cancer


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: Childhood Rectal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: colorectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024


subject: CHEMBL.COMPOUND:CHEMBL1743024

object_name: digestive system cancer


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: UMLS:C2744646


subject: GTOPDB:7986

subject_name: rilotumumab


subject: GTOPDB:7986


subject: GTOPDB:7986


subject: GTOPDB:7986


subject: GTOPDB:7986


subject: GTOPDB:7986


subject: GTOPDB:7986


subject: GTOPDB:7986


subject: GTOPDB:7986


subject: GTOPDB:7986


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UNII:51WEW898IJ


subject: UMLS:C1879711

subject_name: AMG 102


subject: UMLS:C1879711


subject: UMLS:C1879711


subject: UMLS:C1879711


subject: UMLS:C1879711


subject: UMLS:C1879711


subject: UMLS:C1879711


subject: UMLS:C1879711


subject: UMLS:C1879711


subject: UMLS:C1879711


subject: PUBCHEM.COMPOUND:16131310

subject_name: Hepatitis B Vaccines

object_name: Reactivation of hepatitis B viral hepatitis


subject: PUBCHEM.COMPOUND:16131310

object_name: Hepatitis B Reactivation, CTCAE


subject: DRUGBANK:DB11627

subject_name: Hepatitis B Vaccine (Recombinant)


subject: DRUGBANK:DB11627


subject: UMLS:C2240392


subject: UMLS:C2240392


subject: UMLS:C0062527

subject_name: Engerix-B


subject: UMLS:C0062527


subject: PUBCHEM.COMPOUND:53481562

subject_name: Gonadotropin-Releasing Hormone

object_name: hypogonadotropic hypogonadism


subject: PUBCHEM.COMPOUND:53481562

object_name: Klinefelter syndrome


subject: PUBCHEM.COMPOUND:53481562

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:53481562

object_name: familial hyperprolactinemia


subject: PUBCHEM.COMPOUND:53481562

object_name: acquired hyperprolactinemia


subject: PUBCHEM.COMPOUND:53481562

object_name: hyperprolactinemia


subject: PUBCHEM.COMPOUND:53481562

object_name: Kallmann syndrome


subject: CHEBI:5520

subject_name: gonadorelin


subject: CHEBI:5520


subject: CHEBI:5520


subject: CHEBI:5520


subject: CHEBI:5520


subject: CHEBI:5520


subject: CHEBI:5520


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: PR:000008127


subject: UMLS:C0306166

subject_name: Factrel


subject: UMLS:C0306166


subject: UMLS:C0306166


subject: UMLS:C0306166


subject: UMLS:C0306166


subject: UMLS:C0306166


subject: UMLS:C0306166


subject: UMLS:C2987342

object_name: Normal renal function


subject: UMLS:C2987342

object_name: kidney failure


subject: CHEBI:232540

object_name: High grade glioma


subject: CHEBI:232540

object_name: malignant glioma


subject: CHEBI:232540

object_name: anaplastic astrocytoma


subject: CHEBI:232540

object_name: glioblastoma


subject: CHEBI:232540

object_name: Childhood Glioblastoma


subject: CHEBI:232540

object_name: adult glioblastoma


subject: UMLS:C4086591

subject_name: MnSOD Mimetic BMX-001


subject: UMLS:C4086591


subject: UMLS:C4086591


subject: UMLS:C4086591


subject: UMLS:C4086591


subject: UMLS:C4086591


subject: CHEMBL.COMPOUND:CHEMBL4297271


subject: CHEMBL.COMPOUND:CHEMBL4297271


subject: CHEMBL.COMPOUND:CHEMBL4297271


subject: CHEMBL.COMPOUND:CHEMBL4297271


subject: CHEMBL.COMPOUND:CHEMBL4297271


subject: CHEMBL.COMPOUND:CHEMBL4297271


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: alcohol abuse


subject: CHEBI:31236

object_name: alcohol dependence


subject: CHEBI:139072

object_name: Anhedonia


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Acute appendicitis NOS (disorder)


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class

object_name: uveitis


subject: UMLS:C3714803

object_name: Uveitis, CTCAE


subject: UMLS:C3714803

object_name: cystoid macular edema


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:18145


subject: UMLS:C0015491

subject_name: factor IX

object_name: hemophilia B


subject: UMLS:C0015491

object_name: hemophilia B leyden


subject: UMLS:C4048712

subject_name: factor IX complex


subject: UMLS:C4048712


subject: PUBCHEM.COMPOUND:121489720

subject_name: darolutamide

object_name: Hormone sensitive prostate cancer


subject: PUBCHEM.COMPOUND:121489720

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:121489720

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:121489720

object_name: metastatic prostate carcinoma


subject: PUBCHEM.COMPOUND:121489720

object_name: Non-metastatic prostate cancer


subject: CHEBI:68534

subject_name: Enzalutamide


subject: CHEBI:68534


subject: CHEBI:68534


subject: CHEBI:95341

subject_name: Baricitinib

object_name: Takayasu arteritis


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: Depressed mood


subject: CHEBI:28939

object_name: Cancer patients and suicide and depression


subject: CHEBI:28939

object_name: Depressed - symptom


subject: CHEBI:28939

object_name: Depression, CTCAE


subject: UMLS:C3896862

object_name: invasive aspergillosis


subject: CHEBI:64312

subject_name: Memantine

object_name: Huntington disease


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Refractory B Acute Lymphoblastic Leukemia


subject: CHEBI:41879

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: CHEBI:85993

subject_name: Palbociclib


subject: CHEBI:85993


subject: UMLS:C5418080

subject_name: FD Inhibitor ALXN2050

object_name: lupus nephritis


subject: UMLS:C5418080

object_name: IgA Nephropathy


subject: UMLS:C5418080

object_name: IgA nephropathy, susceptibility to, 1


subject: UMLS:C5418080

object_name: lobular neoplasia


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:63791

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:63791

object_name: DS Stage I Plasma Cell Myeloma


subject: CHEBI:63791

object_name: ISS Stage I Plasma Cell Myeloma


subject: CHEBI:63791

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:63791

object_name: ISS Stage II Plasma Cell Myeloma


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: B-cell childhood acute lymphoblastic leukemia


subject: UNII:4FR53SIF3A

object_name: B-cell adult acute lymphocytic leukemia


subject: UNII:4FR53SIF3A

object_name: B-cell acute lymphoblastic leukemia


subject: UNII:4FR53SIF3A

object_name: Childhood B Lymphoblastic Lymphoma


subject: UNII:4FR53SIF3A

object_name: B Lymphoblastic Lymphoma


subject: UNII:4FR53SIF3A

object_name: Adult B Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB


subject: UNII:P93RUU11P7


subject: UNII:P93RUU11P7


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:28887

subject_name: Ofatumumab


subject: CHEBI:28887


subject: CHEBI:28887


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Small cell lung cancer recurrent


subject: UNII:52CMI0WC3Y

object_name: Metastatic Lung Small Cell Carcinoma


subject: UNII:52CMI0WC3Y

object_name: Stage IV Lung Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVB Lung Cancer AJCC v8


subject: UNII:52CMI0WC3Y

object_name: Stage IVA Lung Cancer AJCC v8


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079

object_name: Small cell lung cancer extensive stage


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:44915

subject_name: Propofol

object_name: Long-bone fracture


subject: PUBCHEM.COMPOUND:124389175

object_name: congenital alveolar dysplasia


subject: PUBCHEM.COMPOUND:124389175

object_name: respiratory distress syndrome in premature infants


subject: PUBCHEM.COMPOUND:124389175

object_name: adult acute respiratory distress syndrome


subject: PUBCHEM.COMPOUND:124389175

object_name: newborn respiratory distress syndrome


subject: CHEBI:81567

subject_name: Thyrotropin


subject: CHEBI:81567


subject: CHEBI:81567


subject: CHEBI:81567


subject: CHEBI:35940

subject_name: Protirelin


subject: CHEBI:35940


subject: CHEBI:35940


subject: CHEBI:35940


subject: CHEBI:143658


subject: CHEBI:64816


subject: UMLS:C0733521

subject_name: Ara-C


subject: UMLS:C3273249

subject_name: Topical Wound Spray HP802-247

object_name: epidermolysis bullosa dystrophica


subject: UMLS:C4039583

subject_name: Chimeric antigen receptor

object_name: Primary mediastinal large B-cell lymphoma (PMBCL)


subject: UMLS:C4039583

object_name: Primary mediastinal large B-cell lymphoma refractory


subject: UMLS:C4039583

object_name: Primary mediastinal large B-cell lymphoma recurrent


subject: UMLS:C4039583

object_name: primary mediastinal large B-cell lymphoma


subject: UMLS:C4039583

object_name: T-cell/histiocyte rich large B cell lymphoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: CHEBI:15365

subject_name: Aspirin

object_name: inherited lipid metabolism disorder


subject: CHEBI:15365

object_name: Dyslipidemia


subject: CHEBI:184023

subject_name: Argininosuccinic acid


subject: CHEBI:184023


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:135207


subject: PR:000004321

subject_name: arylsulfatase A


subject: PR:000004321


subject: CHEBI:25503

subject_name: nervonoyl group


subject: CHEBI:25503


subject: PR:000011394

subject_name: oxysterols receptor LXR-beta


subject: PR:000011394


subject: MESH:C039964

subject_name: iberogast

object_name: irritable bowel syndrome


subject: MESH:C039964

object_name: Nonulcer dyspepsia


subject: UMLS:C5552956

subject_name: Direct Oral Anticoagulant

object_name: non-small cell lung carcinoma


subject: UNII:4A2Y23XK11

subject_name: Lazertinib


subject: MESH:D006495

subject_name: Heparin, Low-Molecular-Weight


subject: UMLS:C3536766

subject_name: Low Molecular Weight Heparin [EPC]


subject: CHEBI:3219

subject_name: Bupropion

object_name: dysthymic disorder


subject: CHEBI:36791

subject_name: Escitalopram


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:47499

subject_name: Imipramine

object_name: major depressive disorder


subject: CHEBI:47499


subject: CHEBI:32599

object_name: traumatic encephalopathy


subject: CHEBI:32599

object_name: traumatic brain injury


subject: CHEBI:32599

object_name: Traumatic AND/OR non-traumatic injury


subject: CHEBI:32599

object_name: Injury


subject: CHEBI:231491

object_name: Acute respiratory distress syndrome due to COVID-19


subject: CHEBI:68554

subject_name: Deferiprone

object_name: beta thalassemia major anemia


subject: CHEBI:68554

object_name: Iron Overload


subject: CHEBI:68554

object_name: iron poisoning


subject: CHEBI:68554

object_name: Iron Overload, CTCAE


subject: CHEBI:95165

object_name: sickle cell disease


subject: CHEBI:95165

object_name: leukopenia


subject: CHEBI:95165

object_name: neutropenia


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:50131


subject: CHEBI:50131


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Epistaxis, CTCAE


subject: UNII:2S9ZZM9Q9V

object_name: Epistaxis


subject: UNII:2S9ZZM9Q9V

object_name: hereditary hemorrhagic telangiectasia


subject: UNII:2S9ZZM9Q9V

object_name: telangiectasia, hereditary hemorrhagic, type 1


subject: CHEBI:45783

subject_name: Imatinib

object_name: Disseminated Malignant Neoplasm


subject: CHEBI:45783

object_name: Embolism, Tumor


subject: CHEBI:45783

object_name: Neoplasm Metastasis


subject: UMLS:C0009629

subject_name: Conalbumin


subject: CHEMBL.COMPOUND:CHEMBL2109121

subject_name: DIPHTHERIA TOXOID

object_name: human papilloma virus infection


subject: CHEMBL.COMPOUND:CHEMBL2109121

object_name: HPV-associated cervical carcinoma


subject: UMLS:C0012551

subject_name: diphtheria toxoid vaccine, inactivated


subject: UMLS:C0012551


subject: CHEMBL.COMPOUND:CHEMBL2108875

subject_name: TETANUS TOXOID


subject: CHEMBL.COMPOUND:CHEMBL2108875


subject: UMLS:C0305062

subject_name: Tetanus Toxoid


subject: UMLS:C0305062


subject: UMLS:C0039620

subject_name: Tetanus Vaccine


subject: UMLS:C0039620


subject: UMLS:C0982332

subject_name: acellular pertussis vaccine, inactivated


subject: UMLS:C0982332


subject: CHEBI:125628

subject_name: Alisertib

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:125628

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:125628

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:125628

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:125628

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:125628

object_name: Breast cancer stage III


subject: CHEBI:125628

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:125628

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:125628

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:125628

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:125628

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:125628

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:125628

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:125628

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:125628

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:125628

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:125628

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:125628

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:125628

object_name: invasive breast carcinoma


subject: CHEBI:125628

object_name: Encounter due to estrogen receptor status


subject: CHEBI:125628

object_name: estrogen receptor status


subject: CHEBI:125628

object_name: HER2/Neu Negative


subject: CHEBI:125628

object_name: Postmenopausal


subject: CHEBI:91951

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:91951

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:91951

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Breast cancer stage III


subject: CHEBI:91951

object_name: Stage III Breast Cancer AJCC v6


subject: CHEBI:91951

object_name: Stage IIIC Breast Cancer AJCC v6


subject: CHEBI:91951

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:91951

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:91951

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:91951

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:91951

object_name: Encounter due to estrogen receptor status


subject: CHEBI:91951

object_name: estrogen receptor status


subject: CHEBI:91951

object_name: HER2/Neu Negative


subject: CHEBI:91951

object_name: Postmenopausal


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:17756771

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage III Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:17756771

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Breast cancer stage III


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage III Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IIIC Breast Cancer AJCC v6


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IIIC Breast Cancer AJCC v7


subject: PUBCHEM.COMPOUND:17756771

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IIIA Breast Carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:17756771

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:17756771

object_name: Encounter due to estrogen receptor status


subject: PUBCHEM.COMPOUND:17756771

object_name: estrogen receptor status


subject: PUBCHEM.COMPOUND:17756771

object_name: HER2/Neu Negative


subject: PUBCHEM.COMPOUND:17756771

object_name: Postmenopausal


subject: MESH:D012462

subject_name: Saline Solution, Hypertonic

object_name: cystic fibrosis


subject: CHEBI:194095

subject_name: mitomycin C(1-)

object_name: ureter transitional cell carcinoma


subject: CHEBI:194095

object_name: renal pelvis urothelial carcinoma


subject: CHEBI:27504

subject_name: Mitomycin


subject: CHEBI:27504


subject: CHEBI:31430

subject_name: conivaptan hydrochloride

object_name: Hyponatremia


subject: CHEBI:31430

object_name: Hyponatremia, CTCAE


subject: CHEBI:681850

subject_name: Conivaptan


subject: CHEBI:681850


subject: CHEBI:150712

subject_name: Hyaluronic acid

object_name: Vaginal Dryness, CTCAE 5.0


subject: CHEBI:150712

object_name: Vaginal Dryness, CTCAE 3.0


subject: CHEBI:150712

object_name: Vaginal dryness


subject: CHEBI:150712

object_name: Menopause present (finding)


subject: CHEBI:150712

object_name: Menopause


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: adult brainstem glioma


subject: UNII:2S9ZZM9Q9V

object_name: childhood brain stem glioma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Cerebral Anaplastic Astrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: Childhood Cerebellar Anaplastic Astrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: childhood spinal cord tumor


subject: UNII:2S9ZZM9Q9V

object_name: childhood cerebral astrocytoma


subject: UNII:2S9ZZM9Q9V

object_name: cerebral astrocytoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:72564


subject: CHEBI:45716

subject_name: Vorinostat


subject: CHEBI:45716


subject: CHEBI:45716

object_name: brain stem glioma


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716


subject: CHEBI:45716

object_name: astrocytic tumor


subject: CHEBI:45716


subject: RXCUI:352990

subject_name: Suboxone

object_name: opiate dependence


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: heroin dependence


subject: CHEBI:5790


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: small cell lung carcinoma


subject: PUBCHEM.COMPOUND:135423438

object_name: Small cell lung cancer recurrent


subject: UMLS:C1879771

subject_name: BIBF 1120


subject: UMLS:C1879771


subject: CHEBI:85164


subject: CHEBI:85164


subject: CHEBI:4670

subject_name: Dobutamine

object_name: heart failure


subject: CHEBI:4670

object_name: Heart Failure, CTCAE


subject: MESH:C078972

subject_name: Niferex

object_name: Iron deficiency anemia of pregnancy


subject: MESH:C078972

object_name: hemochromatosis


subject: CHEBI:41423

subject_name: Celecoxib

object_name: nicotine dependence


subject: CHEBI:10112

subject_name: Zileuton


subject: CHEBI:75179

subject_name: Trifluridine

object_name: colorectal cancer


subject: CHEBI:75179

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:71157

subject_name: Dobesilic acid


subject: CHEBI:34741

subject_name: Equol

object_name: Arterial Stiffness


subject: CHEBI:34741

object_name: Mental deterioration


subject: CHEBI:34741

object_name: Cognitive impairment


subject: CHEBI:34741

object_name: White matter lesion


subject: DRUGBANK:DB15654

subject_name: Moderna COVID-19 Vaccine


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: human papillomavirus-related squamous cell carcinoma


subject: UMLS:C4726002

object_name: head and neck squamous cell carcinoma


subject: UMLS:C4726002


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Childhood Breast Carcinoma


subject: CHEBI:100241

object_name: breast carcinoma


subject: CHEBI:100241

object_name: breast cancer


subject: GTOPDB:4934

subject_name: G-CSF


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: CHEBI:36791

subject_name: Escitalopram

object_name: Light for dates


subject: CHEBI:36791

object_name: melancholia


subject: CHEBI:36791

object_name: cardiovascular disorder


subject: CHEBI:36791

object_name: type 2 diabetes mellitus


subject: CHEBI:36791

object_name: Insulin resistance


subject: CHEBI:3723

subject_name: Citalopram


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:3723


subject: CHEBI:42471

subject_name: Colforsin

object_name: glaucoma


subject: CHEBI:42471

object_name: Glaucoma, CTCAE


subject: CHEBI:93891

subject_name: Forskolin


subject: CHEBI:93891


subject: CHEBI:177504

subject_name: Butylphthalide


subject: CHEBI:177504


subject: CHEBI:61606


subject: CHEBI:61606


subject: CHEBI:28527

subject_name: Rutin


subject: CHEBI:28527


subject: CHEBI:18385

subject_name: Thiamine


subject: CHEBI:18385


subject: CHEBI:51707

subject_name: diboron


subject: CHEBI:51707


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: drug-induced liver injury


subject: CHEBI:134722

subject_name: Favipiravir

object_name: Crimean-Congo hemorrhagic fever


subject: UMLS:C4727777

object_name: secondary hyperparathyroidism


subject: CHEBI:28939

object_name: pulmonary sarcoidosis


subject: CHEBI:78432

subject_name: Ceritinib

object_name: lung cancer


subject: CHEBI:78432

object_name: lung neoplasm


subject: CHEBI:78432

object_name: lung carcinoma


subject: CHEBI:78432

object_name: non-small cell lung carcinoma


subject: CHEBI:78432

object_name: Epidermal growth factor receptor negative non-small cell lung cancer


subject: CHEBI:78432

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:78432

object_name: Non-small cell lung cancer stage IIIB


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: UMLS:C2348756

subject_name: Testosterone Gel

object_name: hypoactive sexual desire disorder


subject: CHEBI:42797

subject_name: Gabapentin


subject: CHEBI:42797

object_name: pelvic organ prolapse


subject: UNII:86AZ0G22V2

subject_name: Liothyronine I-131

object_name: congenital heart disease


subject: UNII:86AZ0G22V2

object_name: tricuspid atresia


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: bone marrow failure syndrome


subject: PUBCHEM.COMPOUND:3368

object_name: Hematologic Neoplasm with Germline GATA2 Mutation


subject: PUBCHEM.COMPOUND:3368

object_name: Hematologic Neoplasm with Germline SAMD9 Mutation


subject: PUBCHEM.COMPOUND:3368

object_name: Hematologic Neoplasm with Germline SAMD9L Mutation


subject: PUBCHEM.COMPOUND:3368

object_name: congenital amegakaryocytic thrombocytopenia 1


subject: PUBCHEM.COMPOUND:3368


subject: PUBCHEM.COMPOUND:3368

object_name: paroxysmal nocturnal hemoglobinuria


subject: PUBCHEM.COMPOUND:3368

object_name: inherited sideroblastic anemia


subject: PUBCHEM.COMPOUND:3368

object_name: Diamond-Blackfan anemia


subject: PUBCHEM.COMPOUND:3368

object_name: Aase syndrome


subject: PUBCHEM.COMPOUND:3368

object_name: Shwachman-Diamond syndrome


subject: PUBCHEM.COMPOUND:3368

object_name: Shwachman-Diamond syndrome 1


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:44185


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: CHEBI:61057


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: CHEBI:61049


subject: PUBCHEM.COMPOUND:9296

subject_name: treosulfan


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: PUBCHEM.COMPOUND:9296


subject: CHEBI:31905

subject_name: Nicorandil

object_name: ST-elevation myocardial infarction


subject: CHEBI:31905

object_name: ST Elevation Myocardial Infarction


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Acute lymphoblastic leukemia recurrent


subject: CHEBI:4026

object_name: Recurrent B Acute Lymphoblastic Leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: CHEBI:4026

object_name: Hematopoietic system--Cancer


subject: CHEBI:4027


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Insufficient Anesthesia


subject: CHEBI:9130

object_name: Toxic effect of inhalation gas


subject: CHEBI:9130

object_name: Recall phenomenon


subject: UMLS:C1138626

subject_name: cocoa extract

object_name: Platelet dysfunction


subject: DRUGBANK:DB10977

subject_name: Cocoa


subject: PR:000004970

subject_name: calcium-binding and coiled-coil domain-containing protein 1


subject: UMLS:C0939909

subject_name: Theobroma cacao, cocoa, chocolate


subject: PUBCHEM.COMPOUND:136924190

subject_name: Guadecitabine

object_name: Refractory Colorectal Carcinoma


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IVC Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IV Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IVA Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:136924190

object_name: Stage IVB Colorectal Cancer AJCC v8


subject: PUBCHEM.COMPOUND:136924190

object_name: colorectal adenocarcinoma


subject: PUBCHEM.COMPOUND:136924190

object_name: Metastatic Microsatellite Stable Colorectal Carcinoma


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: cirrhosis due to hepatitis B


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: MESH:C000706407

object_name: bacterial vaginosis


subject: CHEBI:9241

subject_name: Spironolactone

object_name: Pulmonary Hypertension, CTCAE


subject: CHEBI:2676

subject_name: Amoxicillin

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:2676

object_name: agammaglobulinemia


subject: CHEBI:2676

object_name: syndromic agammaglobulinemia


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:100241

subject_name: Ciprofloxacin


subject: CHEBI:100241


subject: CHEBI:100241


subject: CHEBI:3770

subject_name: co-trimoxazole


subject: CHEBI:3770


subject: CHEBI:3770


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:45924


subject: CHEBI:45924


subject: CHEBI:4856

subject_name: Esmolol

object_name: Tachycardia by ECG Finding


subject: CHEBI:4856

object_name: Tachycardia


subject: CHEBI:4856

object_name: hypotension


subject: CHEBI:4856

object_name: Hypotension, CTCAE


subject: CHEBI:135117

subject_name: ftivazide

object_name: Mechanical complication due to intrauterine contraceptive device


subject: CHEBI:6030

subject_name: Isoniazid


subject: CHEBI:7726

subject_name: octreotide

object_name: autosomal dominant polycystic kidney disease


subject: UMLS:C2917414

subject_name: Recombinant Human Deoxyribonuclease 1 [EPC]

object_name: dry eye syndrome


subject: UMLS:C2917414

object_name: Dry Eye, CTCAE


subject: UMLS:C2917414

object_name: Dryness of eye


subject: CHEBI:87715

subject_name: Prasugrel

object_name: ST-elevation myocardial infarction


subject: UNII:GE077RPG04

subject_name: RACLOPRIDE C 11

object_name: traumatic encephalopathy


subject: UNII:GE077RPG04

object_name: traumatic brain injury


subject: UMLS:C5392741

object_name: cystic fibrosis


subject: CHEBI:36791

subject_name: Escitalopram

object_name: temporal lobe epilepsy


subject: CHEBI:3723

subject_name: Citalopram


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin

object_name: HIV infection


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: CHEBI:45285

subject_name: Pyrazinamide


subject: UMLS:C0678171

subject_name: Pentasa

object_name: ulcerative colitis


subject: UMLS:C0678171

object_name: inflammatory bowel disease 1


subject: PR:000013574

subject_name: sulfhydryl oxidase 1

object_name: Advanced Hepatocellular Carcinoma


subject: UNII:76IC00YRVR

subject_name: Luvadaxistat

object_name: schizophrenia


subject: CHEBI:63611

subject_name: Moxifloxacin

object_name: chronic bronchitis


subject: CHEBI:63611

object_name: bronchitis


subject: CHEBI:134724

subject_name: Ipragliflozin

object_name: type 2 diabetes mellitus


subject: HMDB:HMDB0014869

subject_name: Nateglinide


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: chronic progressive multiple sclerosis


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: PR:000022673

subject_name: antigen 43